These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2749256)

  • 21. Simultaneous measurement of opiate-induced histamine release in the periaqueductal gray and opiate antinociception: an in vivo microdialysis study.
    Barke KE; Hough LB
    J Pharmacol Exp Ther; 1993 Aug; 266(2):934-42. PubMed ID: 7689107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia.
    Kiefel JM; Cooper ML; Bodnar RJ
    Brain Res; 1992 Dec; 597(2):331-8. PubMed ID: 1473004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat.
    Jensen TS; Yaksh TL
    Brain Res; 1986 Jan; 363(1):99-113. PubMed ID: 3004644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity.
    Carr DJ; Gebhardt BM; Paul D
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1179-86. PubMed ID: 8383741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.
    Beilin B; Martin FC; Shavit Y; Gale RP; Liebeskind JC
    Brain Behav Immun; 1989 Jun; 3(2):129-37. PubMed ID: 2477090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
    Carr DJ; Gerak LR; France CP
    J Pharmacol Exp Ther; 1994 May; 269(2):693-8. PubMed ID: 8182537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat.
    Morgan MM; Fossum EN; Levine CS; Ingram SL
    Pharmacol Biochem Behav; 2006 Sep; 85(1):214-9. PubMed ID: 16979226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of serotonin in analgesia elicited by morphine in the periaqueductal gray matter (PAG).
    Schul R; Frenk H
    Brain Res; 1991 Jul; 553(2):353-7. PubMed ID: 1681985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat.
    Sharpe LG; Garnett JE; Cicero TJ
    Behav Biol; 1974 Jul; 11(3):303-13. PubMed ID: 4411999
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine.
    Siuciak JA; Advokat C
    Brain Res; 1987 Oct; 424(2):311-9. PubMed ID: 3676830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat.
    Renno WM; Mullett MA; Beitz AJ
    Brain Res; 1992 Oct; 594(2):221-32. PubMed ID: 1450948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of prolactin in response to microinjection of morphine into mesencephalic dorsal raphe nucleus.
    Johnson JH
    Neuroendocrinology; 1982; 35(3):169-72. PubMed ID: 6290924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
    Campion KN; Saville KA; Morgan MM
    Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Opiate receptors and sleep. Effects of microinjections of morphine in the median thalamus and the periaqueductal gray matter of the rabbit (author's transl)].
    Tissot R
    Neuropsychobiology; 1980; 6(3):170-9. PubMed ID: 6246466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats.
    Tortorici V; Nogueira L; Aponte Y; Vanegas H
    Pain; 2004 Nov; 112(1-2):113-20. PubMed ID: 15494191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats.
    Kiefel JM; Rossi GC; Bodnar RJ
    Brain Res; 1993 Oct; 624(1-2):151-61. PubMed ID: 8252387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
    Saurer TB; Ijames SG; Carrigan KA; Lysle DT
    Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.
    Rosén A; Zhang YX; Lund I; Lundeberg T; Yu LC
    Brain Res; 2004 Mar; 1001(1-2):87-94. PubMed ID: 14972657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
    Lysle DT; Coussons ME; Watts VJ; Bennett EH; Dykstra LA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1071-8. PubMed ID: 7685383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.